Article
The Harvard case of Xu Xiping: exploitation of the people, scientific advance, or genetic theft?
New genetics and society - 1 Apr 2005
Sleeboom Margaret
Abstract excerpt
A unique history and make-up of a population may make it an attractive research target for population geneticists and pharmaco-genomic investors. The promise of pharmaceutical profits and advances in medical knowledge attracted Harvard researchers and the company Millennium Pharmaceuticals to remote areas in Anhui Province, Central China, leading to international diplomatic disagreements about issues such as the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
